Skip to main content
. 2023 May 31;13(6):934. doi: 10.3390/jpm13060934

Table 1.

Groups characteristics.

Characteristics SLE LN Control p Significance
Men: women 17/59 11/62 10/50 >0.05
Age (years old) 43.0 ± 6.5 44.1 ± 5.6 41.7 ± 6.5 >0.05
SLEDAI 9.4 ± 4.1 12.9 ± 3.9 - -
Disease duration (years) 5.7 ± 1.4 6.5 ± 1.1 - -
Clinical presentation (%)
Constitutional manifestations
Fatigue 37.4 39.7 - >0.05
Fever 11.2 9.5 - >0.05
Weight loss 7.1 5.7 - >0.05
Cutaneous-mucosal lesions
Vespertilio 38.4 33.7 - >0.05
Photosensitivity 33.9 31.4 - >0.05
Hyperkeratosis/cutaneous atrophy 27.1 22.8 - >0.05
Depigmentation 14.5 12.6 - >0.05
Digital ulcerations 8.2 7.3 - >0.05
Mucosal ulcerations 11.4 9.8 - >0.05
Alopecia 24.1 21.9 - >0.05
Musculoskeletal manifestations
Arthritis/arthralgia 39.7 36.4 - >0.05
Myositis 21.1 17.2 - >0.05
Systolic pressure (mm Hg) 11.9 ± 1.6 13.1 ± 1.4 11.7 ± 2.3 >0.05
Diastolic pressure (mm Hg) 6.8 ± 0.8 7.1 ± 0.8 6.9 ± 0.9 >0.05
Laboratory data
Leukocytes (cells/mmc) 3700 ± 2103 4022 ± 1051 5426 ± 1210 >0.05
Hemoglobin (g/dL) 10.7 ± 1.4 10.1 ± 1.1 13.1 ± 1.3 >0.05
Urea (mg/dL) 28.5 ± 11.7 36.0 ± 12.5 22.5 ± 7.6 >0.05
Creatinine (mg/dL) 0.9 ± 0.11 1.27 ± 0.19 0.68 ± 0.19 >0.05
eGFR (ml/min/1.73mp) 79.4 ± 16.8 44.7 ± 12.6 87.5 ± 14.2 >0.05
Hematuria (sw—RBC/camp) 5 ± 2 37 ± 8 1 ± 1 >0.05
Leukocyturia (sw—leuc/camp) 10 ± 2 9.3 ± 1.9 3.8 ± 2.9 >0.05
Albuminuria (mg/L) 0.012 ± 0.0003 1900 ± 1175 0.0001 ± 0.0001 <0.001
Albumin (g/dL) 3.72 ± 0.32 3.41 ± 0.29 4.11 ± 0.37 >0.05

Vespertilio—an erythematous rash in butterfly wings on the nose and dorsal face and at the zygomatic level.